Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliot C Williams

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|August 13, 2008
Cytogenetically normal acute myeloid leukemiaWael Saber, Eliot C Williams
Neurocritical Care|June 30, 2011
Cerebellar hemorrhage as a first presentation of acquired Hemophilia ADejan Micic, Eliot C Williams, Joshua E Medow
International Journal of Clinical and Experimental Pathology|September 12, 2008
Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancyKen H Young, Dahua Zhang, Jeffery T Malik, et al.
Blood Advances|October 7, 2021
Doppler ultrasound screening in patients with newly diagnosed heparin-induced thrombocytopeniaElyse I Harris, Luke D Zurbriggen, Matthew J Brunner, et al.
AJR. American Journal of Roentgenology|November 26, 2009
Coagulation concepts updateStacy D O'Connor, Andrew J Taylor, Eliot C Williams, et al.
Case Reports in Hematology|August 22, 2022
Unexplained Hematocrit Increase after Therapeutic Phlebotomy in a Patient with Marked ErythrocytosisRushad Machhi, Ashley M Cunningham, Kenneth Hennrick, et al.
Pathology, Research and Practice|December 25, 2002
Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activityThomas F Warner, David A Wrone, Eliot C Williams, et al.
Cancer Investigation|April 25, 2007
A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomasLisa A Kujawski, Walter L Longo, Eliot C Williams, et al.
Leukemia & Lymphoma|December 5, 2008
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemiaJulie E Chang, Stephen C Medlin, Brad S Kahl, et al.
Cancer Investigation|March 23, 2005
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network StudyBrad S Kahl, Howard H Bailey, Eileen P Smith, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|August 13, 2008
Cytogenetically normal acute myeloid leukemiaWael Saber, Eliot C Williams
Neurocritical Care|June 30, 2011
Cerebellar hemorrhage as a first presentation of acquired Hemophilia ADejan Micic, Eliot C Williams, Joshua E Medow
International Journal of Clinical and Experimental Pathology|September 12, 2008
Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancyKen H Young, Dahua Zhang, Jeffery T Malik, et al.
Blood Advances|October 7, 2021
Doppler ultrasound screening in patients with newly diagnosed heparin-induced thrombocytopeniaElyse I Harris, Luke D Zurbriggen, Matthew J Brunner, et al.
AJR. American Journal of Roentgenology|November 26, 2009
Coagulation concepts updateStacy D O'Connor, Andrew J Taylor, Eliot C Williams, et al.
Case Reports in Hematology|August 22, 2022
Unexplained Hematocrit Increase after Therapeutic Phlebotomy in a Patient with Marked ErythrocytosisRushad Machhi, Ashley M Cunningham, Kenneth Hennrick, et al.
Pathology, Research and Practice|December 25, 2002
Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activityThomas F Warner, David A Wrone, Eliot C Williams, et al.
Cancer Investigation|April 25, 2007
A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomasLisa A Kujawski, Walter L Longo, Eliot C Williams, et al.
Leukemia & Lymphoma|December 5, 2008
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemiaJulie E Chang, Stephen C Medlin, Brad S Kahl, et al.
Cancer Investigation|March 23, 2005
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network StudyBrad S Kahl, Howard H Bailey, Eileen P Smith, et al.
Pageof 2